Antiemetics are therapeutic agents that are effective against nausea and vomiting. Nausea and vomiting are the symptoms of several medical conditions such as motion sickness, dizziness, pregnancy, emotional stress and food poisoning.
These drugs are often used to treat the side effects of other medications including opioid analgesics, Chemotherapy and general anesthetics.

The global Antiemetics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antiemetics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antiemetics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Antiemetics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Antiemetics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
GlaxoSmithKline
Merck
Sanofi Aventis
Bristol Myers Squibb
Eli Lilly
Pfizer
Astellas
Johnson & Johnson
Baxter

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
5-HT3 receptor antagonists
Dopamine antagonists
NK1 receptor antagonist
Antihistamines (H1 histamine receptor antagonists)
Cannabinoids
Benzodiazepines
Anticholinergics
Steroids
Others

Segment by Application
Chemotherapy
Motion sickness
Gastroenteritis
General anesthetics
Opioid analgesics
Dizziness
Pregnancy
Food poisoning
Emotional stress
Others